288 related articles for article (PubMed ID: 29796115)
1. miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.
Li W; Yi J; Zheng X; Liu S; Fu W; Ren L; Li L; Hoon DSB; Wang J; Du G
Clin Epigenetics; 2018; 10():64. PubMed ID: 29796115
[TBL] [Abstract][Full Text] [Related]
2.
Deng L; Yin Q; Liu S; Luo D
Dis Markers; 2022; 2022():5699275. PubMed ID: 36061358
[TBL] [Abstract][Full Text] [Related]
3. Loss of post-transcriptional regulation of DNMT3b by microRNAs: a possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell lines.
Sandhu R; Rivenbark AG; Coleman WB
Int J Oncol; 2012 Aug; 41(2):721-32. PubMed ID: 22664488
[TBL] [Abstract][Full Text] [Related]
4. miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma.
Wu H; Zhang W; Wu Z; Liu Y; Shi Y; Gong J; Shen W; Liu C
Cell Death Dis; 2019 Jan; 10(2):48. PubMed ID: 30718452
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1.
Liu DZ; Chang B; Li XD; Zhang QH; Zou YH
Clin Transl Oncol; 2017 Sep; 19(9):1133-1140. PubMed ID: 28397066
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer.
Sandhu R; Rivenbark AG; Mackler RM; Livasy CA; Coleman WB
Int J Oncol; 2014 Feb; 44(2):563-72. PubMed ID: 24297604
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression.
Song B; Wang C; Liu J; Wang X; Lv L; Wei L; Xie L; Zheng Y; Song X
J Exp Clin Cancer Res; 2010 Mar; 29(1):29. PubMed ID: 20346171
[TBL] [Abstract][Full Text] [Related]
8. MiR-124-3p suppresses bladder cancer by targeting DNA methyltransferase 3B.
Zo RB; Long Z
J Cell Physiol; 2018 Jan; 234(1):464-474. PubMed ID: 29893409
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-21 promotes proliferation, migration, and invasion of cervical cancer through targeting TIMP3.
Zhang Z; Wang J; Wang X; Song W; Shi Y; Zhang L
Arch Gynecol Obstet; 2018 Feb; 297(2):433-442. PubMed ID: 29177591
[TBL] [Abstract][Full Text] [Related]
10. Suppressing microRNA-29c promotes biliary atresia-related fibrosis by targeting DNMT3A and DNMT3B.
Wang JY; Cheng H; Zhang HY; Ye YQ; Feng Q; Chen ZM; Zheng YL; Wu ZG; Wang B; Yao J
Cell Mol Biol Lett; 2019; 24():10. PubMed ID: 30906331
[TBL] [Abstract][Full Text] [Related]
11. DNMT3B silencing suppresses migration and invasion by epigenetically promoting miR-34a in bladder cancer.
Xu K; Chen B; Li B; Li C; Zhang Y; Jiang N; Lang B
Aging (Albany NY); 2020 Nov; 12(23):23668-23683. PubMed ID: 33221743
[TBL] [Abstract][Full Text] [Related]
12. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
[TBL] [Abstract][Full Text] [Related]
13. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
14. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
[TBL] [Abstract][Full Text] [Related]
15. Demethylation of TIMP2 and TIMP3 Inhibits Cell Proliferation, Migration, and Invasion in Pituitary Adenomas.
Yang Y; Huang F; Wu X; Huang C; Li Y
Discov Med; 2024 May; 36(184):971-980. PubMed ID: 38798256
[TBL] [Abstract][Full Text] [Related]
16. MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1.
Zhang LY; Chen Y; Jia J; Zhu X; He Y; Wu LM
Cancer Biomark; 2019; 24(1):31-42. PubMed ID: 30614794
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma.
Nguyen T; Kuo C; Nicholl MB; Sim MS; Turner RR; Morton DL; Hoon DS
Epigenetics; 2011 Mar; 6(3):388-94. PubMed ID: 21081840
[TBL] [Abstract][Full Text] [Related]
18. microRNA-451a promoter methylation regulated by DNMT3B expedites bladder cancer development via the EPHA2/PI3K/AKT axis.
Liu B; Sun W; Gao W; Li L; Cao Z; Yang X; Liu J; Guo Y
BMC Cancer; 2020 Oct; 20(1):1019. PubMed ID: 33087088
[TBL] [Abstract][Full Text] [Related]
19. MiR-29b suppresses proliferation and mobility by targeting SOX12 and DNMT3b in pancreatic cancer.
Wang L; Wang Z; Huang L; Wu C; Zhang B
Anticancer Drugs; 2019 Mar; 30(3):281-288. PubMed ID: 30601190
[TBL] [Abstract][Full Text] [Related]
20. CCND1, NOP14 and DNMT3B are involved in miR-502-5p-mediated inhibition of cell migration and proliferation in bladder cancer.
Ying Y; Li J; Xie H; Yan H; Jin K; He L; Ma X; Wu J; Xu X; Fang J; Wang X; Zheng X; Liu B; Xie L
Cell Prolif; 2020 Feb; 53(2):e12751. PubMed ID: 31971654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
